Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.
Reports show lung cancer mortality in Ohio is decreasing, but the disease remains the leading cause of cancer deaths in ...
Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
OPINION: Stanford Dr. Bryant Lin is both a patient and an advocate in yet another vexing health care problem: insurance ...
For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...
As with many types of cancer, early detection of lung cancer is critical for improving health outcomes, and advances in robotic technology have become essential tools in early screening and ...
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Single Anesthesia Bronchoscopy and Resection (SABR) was implemented at Riverside and is said to advance lung cancer care.
FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...
Foundation funds eleven new research projects. NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) awarded its annual 2025 Scientific Grant Program ...
PUSH FOR BETTER LUNG CARE Led by the Lung Health Alliance of the Philippines (LungHAP), medical experts, patient groups and ...